Showing 12 out of 2273 items
- Chronic HIV infection is associated with relatively high levels of inflammation and a growing body of evidence suggests that inflammation may increase the risk ...
- As mentioned earlier in this issue of TreatmentUpdate, chronic HIV infection is associated with excessive levels of inflammation and activation of the immune ...
- Pitavastatin is approved in the U.S. but not yet in Canada for the normalization of cholesterol levels. A clinical trial of pitavastatin, called Reprieve, is ...
- Chronic HIV infection is associated with increased levels of inflammation. Researchers suspect that over the long-term this inflammation may be associated with ...
- Canakinumab is an antibody that has been designed to block a receptor on cells for the chemical signal (cytokine) IL-1b (interleukin-1beta). This receptor and ...
- In a double-blind, placebo-controlled, randomized study called Cantos, researchers gave placebo and different doses of canakinumab (sold as Ilaris) every three ...
- Canakinumab is an antibody that is used to treat rare inflammatory conditions. It works by interfering with a receptor for the chemical signal interleukin-1b ...
- As mentioned earlier in this issue of TreatmentUpdate, the antibody canakinumab, in a study called Cantos, showed modest benefits in reducing the risk of heart ...
- As mentioned earlier in this issue of TreatmentUpdate, chronic HIV infection is associated with inflammation. Initiating HIV treatment (ART) and achieving and ...
- SIV (simian immunodeficiency virus) is closely related to HIV. In some monkeys, SIV infection causes a syndrome similar to AIDS. Researchers sometimes use ...
- A number of clinical trials are underway to study therapies that can help reduce inflammation and have other beneficial effects in people on HIV treatment ...